Long-term effects of intermittent IL-2 in HIV infection: extended follow-up of the INSIGHT STALWART Study.

Autor: Norman Markowitz, Gustavo Lopardo, Deborah Wentworth, Daniela Gey, Abdel Babiker, Lawrence Fox, Jorge Tavel, STALWART Study Group

Publikováno v: PLoS ONE, Vol 7, Iss 10, p e47506 (2012)

The Study of Aldesleukin with and without Antiretroviral Therapy (STALWART) was designed to evaluate whether intermittent IL-2 alone or with peri-cycle ART increased CD4+ cell counts (and so delayed initiation of ART) in HIV infected individuals havi

Externí odkaz: https://doaj.org/article/f75fb8808034404a901593f528476484

Risk of cancers during interrupted antiretroviral therapy in the SMART study

Autor: James D. Neaton, Jose Hidalgo, Keith Henry, Michael J. Silverberg, Daniela Gey, Jacqueline Neuhaus, Mark Bower, Leonardo Lourtau, Giuseppe Tambussi, Donald I. Abrams, Angelos Hatzakis

Publikováno v: AIDS. 21:1957-1963

To compare rates of AIDS-defining and non-AIDS-defining malignancies between patients on a CD4 T-cell-guided antiretroviral therapy (ART) strategy and continuous ART.A randomized clinical trial.Malignancy rates were compared between the drug conserva

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fdec814e47f852cfb2c4006d713b241
https://doi.org/10.1097/qad.0b013e3282ed6338

Effects of intermittent IL-2 alone or with peri-cycle antiretroviral therapy in early HIV infection: the STALWART study

Autor: Wafaa El-Sadr, David A. Cooper, Nicki Smith, Gregg Larson, Patty Bollenbeck, John Worley, Chloe Orkin, Daniela Gey, Andrzej Horban, Maxime Seligmann, Greg Thompson, Ray Nelson, David Courtney-Rodgers, Valerie Beral, Adriana Sanchez, John Chuah, Karoline Jensen, Ann M. Labriola, Jens D Lundgren, Ronald J. Prineas, Marcelo H. Losso, Richard J. Price, Billy Pick, Maria C. Rodriguez-Barradas, Norman Markowitz, J Vera, Bitten Aagaard, Karen Hennessey, Gustavo Lopardo, Cate Carey, Daniel E. Nixon, Eileen Denning, Liselotte Borup, Barbara E. Murray, Richard E. Chaisson, Christopher Hill, Kamal Mansinho, Martin J. Wiselka, Shawn K. Brown, Hakima Himmich, Jo Watson, Fionna Van Hooff, Janet Darbyshire, Frank S. Rhame, Jessica Horton, Court Pederson, Jesper Grarup, John F. Modlin, Jonathan P. Anderson, Dwight E. Peavy, Claire Rappoport, Merrie Harrison, Siu Fun L. Quan, Barbara Standridge, Julie Eckstrand, Pacharee Kantipong, Fred M. Gordin, Jorge A. Tavel, Ana Martinez, Juan Carlos López, Lisa Fosdick, Ploenchan Chetchotisakd, Ian Weller, James D. Neaton, Doug Thomas, Elizabeth Finley, Simon Portsmouth, Mirta Valdez, Waldo H. Belloso, Giuseppe Tambussi, Nicholas I. Paton, Vanita Costas, Nafisah Braimah, Sergio H. Lupo, Simon Collins, Terri Schultz, Siegfried Schwarze, David Haerry, Kien Quan, Daniel Duprez, James H. Sampson, Thomas R. Fleming, Kyung Mann Kim, Eric A. Krum, Gregory M. Anstead, Matthew Bidwell Goetz, Marcelo Wolff, Deborah Wentworth, Stefano Rusconi, Søren Reilev, Abdel Babiker, Eleanor King, Francisco Antunes, Sean Emery, David Orth, Per O. Jansson, Lawrence Fox, Martin Fisher, Mary Anne Luzar, Alan R. Lifson, David Mollerup, Rick Davey, Alan Winston, Jenny Hoy, Kiat Ruxrungtham, Michael Meulbroek, Nicole Wyman, Judith Bebchuk, José M. Gatell, Alain G. DuChene, David Munroe, Roberto C. Arduino, George Perez, Mark James Kelly

Publikováno v: PLoS ONE
PLoS ONE, Vol 5, Iss 2, p e9334 (2010)
PloS one, vol 5, iss 2
Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de la UB
Universidad de Barcelona

BACKGROUND: The Study of Aldesleukin with and without antiretroviral therapy (STALWART) evaluated whether intermittent interleukin-2 (IL-2) alone or with antiretroviral therapy (ART) around IL-2 cycles increased CD4(+) counts compared to no therapy.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e02e4546eb935338438cf232f726b50
http://ora.ox.ac.uk/objects/uuid:aef3f5ca-a828-42a6-b782-9f2e9ba8babc